 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This is a signal that AVXL's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Anavex Life Sciences (AVXL, $7.13) RSI Indicator left the oversold zone on September 18, 2023

Significant Reduction of Amyloid Beta Biomarkers of Alzheimer s PathologyNEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ( Anavex or the Company ) (Nasdaq: AVXL), a...

Anavex s Phase 2b/3 Trial of Blarcamesine (ANAVEX 2-73) in Patients with Alzheimer s Disease Shows Robust Clinical Efficacy and Slows Neurodegeneration

This is a signal that AVXL's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Anavex Life Sciences (AVXL, $7.66) Stochastic Oscillator left the oversold zone on September 13, 2023

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Anavex Life Sciences Corp (AVXL), where a total of 7,759 contracts have traded so far...

Noteworthy Wednesday Option Activity: AVXL, BJRI, COIN

Anavex Life Sciences (AVXL, $7.75) Stochastic Oscillator left the oversold zone on September 12, 2023

NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ( Anavex or the Company ) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics...

Anavex Announces Appointment of Dr. Marwan N Sabbagh, MD as Chairman of the Scientific Advisory Board

Anavex Life Sciences (AVXL, $7.75) Stochastic Oscillator left the oversold zone on September 11, 2023

This indicator may be signaling AVXL's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Anavex Life Sciences (AVXL, $7.87) entered Uptrend as Momentum indicator ascends above 0 level on Sep 08, 2023

Anavex Life Sciences (AVXL, $7.9) Stochastic Oscillator left the oversold zone on August 31, 2023

Anavex Life Sciences (NASDAQ:AVXL Get Free Report) and Repligen (NASDAQ:RGEN Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, ...

Comparing Anavex Life Sciences (NASDAQ:AVXL) and Repligen (NASDAQ:RGEN)

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Watchers	19,173
52-Wk Low	$6.74
52-Wk High	$15.24

Market Cap	$557.27M
Volume (M)	606,126.00
52-Wk High	$15.24
52-Wk Low	$6.74

AVXL Anavex Life Sciences Corporation

About

Feed

News

Sentiment

Earnings

Fundamentals